Literature DB >> 16172808

Eosinophil infiltration in three patients with generalized atrophic benign epidermolysis bullosa from a Japanese family: molecular genetic and immunohistochemical studies.

Masayo Nomura1, Yoh-Ichiro Hamasaki2, Ichiro Katayama3, Kuniko Abe4, Norio Niikawa1,5, Koh-Ichiro Yoshiura6,7.   

Abstract

Generalized atrophic benign epidermolysis bullosa (GABEB), a subtype of epidermolysis bullosa (EB), is an autosomal recessive skin disease characterized by derm-epidermal separation leading to skin fragility and atrophy and other associated abnormalities. Although a few reports demonstrated that eosinophils are infiltrating beneath bullas in infants with some types of EB, no such condition in adult GABEB patients has been known. Here we report on three adult patients with GABEB from a Japanese family, whose bullous skin lesions showed massive eosinophil infiltration. One of the three patients showed amyloid deposition at the intestine, kidney, and skin. Linkage analysis revealed that GABEB in the family was linked to COL17A1 with a maximum LOD score of 3.08. Mutation analysis identified in the three patients a homozygous insertional mutation, 209-210insCA, in exon 5 of COL17A1. The expression of mutated COL17A1 was confirmed by semiquantitative RT-PCR, but no signals for truncated COL17A1 protein were detected by the immunohistochemical studies using antibodies against BP180. Furthermore, no autoantibody against the mutant protein was detected by western blot analysis. It is thus less likely that autoantibody and/or a local immune reaction in their skin has a primary role in eosinophil infiltration in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172808     DOI: 10.1007/s10038-005-0282-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  19 in total

Review 1.  Dystrophic epidermolysis bullosa associated with eosinophilic infiltrate and elevated serum IgE.

Authors:  M H Grunwald; B Amichai; I Avinoach; T Kedar; R Bergman
Journal:  Pediatr Dermatol       Date:  1999 Jan-Feb       Impact factor: 1.588

Review 2.  BP180 (type XVII collagen) and its role in cutaneous biology and disease.

Authors:  Françoise Van den Bergh; George J Giudice
Journal:  Adv Dermatol       Date:  2003

Review 3.  Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts.

Authors:  Monika Bowszyc-Dmochowska; Marian Dmochowski
Journal:  J Med       Date:  2002

4.  Eosinophilic infiltrates in epidermolysis bullosa.

Authors:  R R Roth; K J Smith; W D James
Journal:  Arch Dermatol       Date:  1990-09

5.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

6.  Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa.

Authors:  H Schumann; N Hammami-Hauasli; L Pulkkinen; A Mauviel; W Küster; U Lüthi; K Owaribe; J Uitto; L Bruckner-Tuderman
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

7.  Generalized atrophic benign epidermolysis bullosa.

Authors:  H Hintner; K Wolff
Journal:  Arch Dermatol       Date:  1982-06

Review 8.  Bullous pemphigoid: end of the century overview.

Authors:  Z Liu; L A Diaz
Journal:  J Dermatol       Date:  2001-11       Impact factor: 4.005

9.  Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti.

Authors:  S Jean-Baptiste; E A O'Toole; M Chen; J Guitart; A Paller; L S Chan
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 10.  Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy.

Authors:  J W Bauer; C Lanschuetzer
Journal:  Clin Exp Dermatol       Date:  2003-01       Impact factor: 3.470

View more
  1 in total

Review 1.  A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.

Authors:  Payal M Patel; Virginia A Jones; Christy T Behnam; Giovanni Di Zenzo; Kyle T Amber
Journal:  Antibodies (Basel)       Date:  2021-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.